Chemoinformaics analysis of 2,4-Dimethyl-3-pentanone
| Molecular Weight | 114.188 | nRot | 2 |
| Heavy Atom Molecular Weight | 100.076 | nRig | 1 |
| Exact Molecular Weight | 114.104 | nRing | 0 |
| Solubility: LogS | -0.738 | nHRing | 0 |
| Solubility: LogP | 1.904 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 21.8271 |
| nHD | 0 | BPOL | 14.9129 |
| QED | 0.535 |
| Synth | 2.245 |
| Natural Product Likeliness | 0.303 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.015 |
| CACO-2 | -4.263 |
| MDCK | 0.0000271 |
| BBB | 0.992 |
| PPB | 0.694164 |
| VDSS | 1.72 |
| FU | 0.392335 |
| CYP1A2-inh | 0.371 |
| CYP1A2-sub | 0.839 |
| CYP2c19-inh | 0.051 |
| CYP2c19-sub | 0.942 |
| CYP2c9-inh | 0.037 |
| CYP2c9-sub | 0.229 |
| CYP2d6-inh | 0.013 |
| CYP2d6-sub | 0.469 |
| CYP3a4-inh | 0.017 |
| CYP3a4-sub | 0.365 |
| CL | 6.642 |
| T12 | 0.734 |
| hERG | 0.011 |
| Ames | 0.208 |
| ROA | 0.069 |
| SkinSen | 0.159 |
| Carcinogencity | 0.074 |
| EI | 0.968 |
| Respiratory | 0.346 |
| NR-Aromatase | 0.002 |
| Antiviral | No |
| Prediction | 0.95604 |